King & Wood Mallesons
Overview
King & Wood Mallesons has approximately 380 partners and 1,800 lawyers across Australia, Asia, New York, Silicon Valley and London. We are the largest law firm in Asia, and the largest firm in the world headquartered outside of the US and UK. We are the market leader in three of the world’s most dynamic economies: Mainland China, Australia and Hong Kong.
King & Wood Mallesons’ intellectual property and life sciences team provides commercially focused, strategic legal advice across a broad range of areas including mergers and acquisitions, commercial legal advice, regulatory and administrative law advice, product liability, freedom to operate advice, pharmaceutical pipeline clearance strategies, patent and trade mark registration, as well as litigation and dispute resolution.
We advise clients across a broad spectrum of commercial ventures, and at all stages of the technology development cycle, including acquisitions and divestitures, venture capital and spin offs, joint ventures and collaborations, research and development agreements, clinical trial agreements, licensing of products and technology, technology transfers, technology creation and IP management, manufacturing and supply agreements, distribution, co-marketing and co-promotion transactions, and compliance with the Therapeutic Goods Act and Medicines Australia Code of Conduct.
The team has an established reputation for providing cutting edge advice in life sciences. In patent litigation, our team has an exceptional track record in a number of Australia's leading patent cases, including advising and running litigation for such leading pharmaceutical companies as Hospira, Alphapharm, Watson, Ranbaxy and Aspen. Our lawyers are known for achieving the commercial goals of our clients in a cost effective and efficient manner.
Our team’s market-leading litigators, commercial lawyers, patent attorneys, and trade mark attorneys possess both technical qualifications and industry experience across many sectors, including pharmaceuticals and biotechnology. Members of our team have scientific training in a range of areas including, pharmacology, chemistry, biochemistry, molecular biology, genetics, physiology and bioinformatics.
Some of our life sciences lawyers currently sit on committees of leading research institutes, and others lecture at leading Australian universities. Members of our life sciences team have previously worked for leading companies and research organisations in the biotechnology industry. This provides our team with a well-rounded understanding of the technology and developments in biotechnology both within Australia and overseas.
Our team’s experience and expertise has been recognised internationally through numerous awards, including:
- A first tier ranking for IP in Australia by Chambers Global Guide 2012
- A first tier ranking for IP in Australia by Legal 500 Australia 2012
- A first tier ranking for IP for the Asia Pacific region by Asia Pacific Legal 500 2012
- A first tier ranking for Australia and China (contentious) by Managing Intellectual Property Global Awards Patent Survey 2012
- Leading IP firm (contentious) – China, Managing Intellectual Property Global Awards 2012.
Number of employees: apx 1800
Main business focus/
Listing by sector:
- Service Provider
Contact Details
| Contact person | Wayne McMaster |
|---|---|
| Job Title | Partner |
| Address | Level 50, Bourke Place |
| 600 Bourke Street | |
| City/Suburb | Melbourne |
| State | Victoria |
| wayne.mcmaster@au.kwm.com | |
| Phone | +61 3 9643 4407 |
| Fax | +61 3 9643 5999 |
| Website | http://www.kwm.com |
